Evidence map›Paper›PMID 28695142›Full record

ArticleOpen forum infectious diseases2017

Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus.

Leangelo N Hall, Laura R Sanchez, Jane Hubbard, Hang Lee, Sara E Looby, Suman Srinivasa, Markella V Zanni, Takara L Stanley, Janet Lo, Steven K Grinspoon and 1 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Leangelo N HallHarvard Medical School, Boston, Massachusetts.
Laura R SanchezProgram in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston.
Jane HubbardClinical Research Center, Massachusetts General Hospital, Boston.
Hang LeeMGH Biostatistics Center and Harvard Medical School, Boston, Massachusetts.
Sara E LoobyProgram in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston.
Suman SrinivasaProgram in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston.
Markella V ZanniProgram in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston.
Takara L StanleyProgram in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston.
Janet LoProgram in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston.
Steven K GrinspoonProgram in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston.
Kathleen V FitchProgram in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston.
Harvard University · USMassachusetts General Hospital · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
ZD6416 Analgesic--Painful Distal Symmetrical PolyneuropaM01RR001066 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, EMERY N · 1985 to 2008
$37.4M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHRISTOPHER P DUGGAN · 1994 to 2026
$31.6M
Harvard Clinical and Translational Science Center (UL1)UL1TR000170 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2012 to 2013
$31.4M
NCATS NIH HHS UL1 TR000170NCRR NIH HHS M01 RR001066NCRR NIH HHS UL1 RR025758NIDDK NIH HHS P30 DK040561
6 · The paper itself

Abstract

backgroundDietary sweeteners may contribute to metabolic dysregulation and cardiovascular disease (CVD), but this has not been assessed in human immunodeficiency virus (HIV).

methodsOne hundred twenty-four HIV-infected and 56 non-HIV-infected participants, without history of known coronary artery disease were included. Dietary intake was assessed using a 4-day food record. Coronary plaque was determined using cardiac computed tomography angiography.

resultsHuman immunodeficiency virus-infected participants had significantly greater intake of dietary sweeteners, including total sugar (

conclusionsWe demonstrate increased intake of dietary sweeteners and a potential novel association between aspartame intake, plaque burden, and inflammation in HIV. Our data suggest that aspartame may contribute to CVD risk in HIV. Further studies should address potential mechanisms by which aspartame may contribute to increased plaque burden and cardiovascular benefits of dietary strategies targeting aspartame intake in HIV.

Indexed as

aspartameatherosclerosisdietary sweetenersHIVinflammation.

Identifiers

PMID28695142
PMCPMC5499744
OpenAlexW2609668942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.